He is also the Director of Japanese Surgical Society and the President of Japanese Society of Regenerative Medicine. He earned a medical degree from Osaka University Medical School in 1980 and joined the First Department of Surgery, Osaka University School of Medicine. In 1989, he earned Humboldt scholarship to pursue further education in both the departments of cardiovascular physiology and cardiac surgery at the Max-Planck Institute in Germany. After returning to Japan, he became Chief surgeon at the Department of Cardiovascular Surgery in 2004, Professor and Chief at the Department of Cardiovascular Surgery, the Director at Medical Center for Translational Research at Osaka University Hospital in 2006. He was appointed to the Dean at Osaka University Graduate School of Medicine from 2015 – March 2017.
Diana O. Perkins
Dr. Perkins is a Professor of Psychiatry at UNC-Chapel Hill School of Medicine. She is a fellow of Consultation/Liaison Psychiatry and the Medical Director of OASIS (Outreach and Support Intervention Services) at UNC Hospitals and the UNC-Chapel Hill School of Medicine. OASIS is an innovative program for individuals recovering from a first psychotic episode or individuals at risk of psychosis. The mission of OASIS and STEP is to enhance recovery from psychosis, to support research that investigates the causes and treatments of psychotic disorders, and to train future clinicians to better treat psychotic disorders.
Dr. Perkins received her medical degree in 1984 from the University of Maryland School of Medicine in Baltimore. She completed her psychiatric residency at the University of Maryland Hospitals and University of North Carolina (UNC) Hospitals, where she was chief resident, and obtained her MPH in epidemiology in 1992 from the UNC-Chapel Hill School of Public Health. Prior to this, Dr. Perkins received her BS in Psychology and in Biochemistry at the University of Maryland.
Dr. Perkins’ primary research interests include early identification and treatment of schizophrenia, emphasizing treatment of the prodromal period, and early intervention of the first episode of schizophrenia. She is currently investigating pharmacological and psychotherapeutic treatments in the treatment of psychosis, focusing on managing the side effects of atypical antipsychotic medications and the weight gain mechanism in patients taking psychotropic medications, including the health risks associated with weight gain. Dr. Perkins is also investigating the genetic basis of schizophrenia.